HomeNewsNeuroscienceSchizophrenia

  • Cadent announces FDA Clearance of IND of CAD-9303 for Schizophrenia

    • March 11, 2020
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • FDA Approves Perseris (risperidone) for Schizophrenia treatment in Adults

    • August 6, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • FDA Approves new Initiation drug, ARISTADA INITIO, for Schizophrenia

    • July 3, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • Rxulti (brexpiprazole) for Schizophrenia gets positive CHMP opinion by EMA

    • June 3, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • Recent study identified Brain cells underlying Schizophrenia

    • May 23, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • Alkermes to Present Clinical Data related to Schizophrenia and Depression at American Psychiatric Association Annual Meeting

    • May 2, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more

  • Schizophrenia drug ALKS 3831 completes Patient enrollment in a pivotal study

    • April 27, 2018
    • Posted by: Pharmascroll
    • Category:
    No Comments
    read more
SPEAK TO AN EXPERT